New research finds that metered-dose inhalers, the most commonly prescribed type in the U.S., account for 98% of the total emissions attributed to inhalers. But there are other options patients and providers can consider.
New research finds that metered-dose inhalers, the most commonly prescribed type in the U.S., account for 98% of the total emissions attributed to inhalers. But there are other options patients and providers can consider.